Category: Drug therapies

All Podcast Categories
S4-11.5 - Excitement and Trepidations: Exploring the Year Ahead in Fatty Liver

S4-11.5 – Excitement and Trepidations: Exploring the Year Ahead in Fatty Liver

This final segment with Jeff McIntyre of the Global Liver Institute (GLI) wraps up discussion around what’s happening in NAFLD and NASH for the first quarter of an exciting year. Roger Green invites the panelists to provide the most significant and optimistic thing they will be touching over the next three months followed by the greatest fear each has in the same space.

S4-11.4 - Increasing Incidence of Type-2 Diabetes Among Adolescents

S4-11.4 – Increasing Incidence of Type-2 Diabetes Among Adolescents

The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking discussion on increasing incidence of Type-2 diabetes among adolescents. The group shares ideas around what’s contributing to this swelling burden and how to dampen its devastating impact.

S4-11.3 - Fighting for Fair Regulation Around What’s Deemed “Healthy”

S4-11.3 – Fighting for Fair Regulation Around What’s Deemed “Healthy”

The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking session around bringing hepatology to the public health dinner table. This conversation explores what’s going on in the assessment of package nutrition labeling and fighting for fair regulation around what’s deemed “healthy.”

S4-11 - The Yin and Yang of Technology and Regulation

S4-11 – The Yin and Yang of Technology and Regulation

The Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking impromptu session on what’s happening thus far for the Fatty Liver field in 2023. They discuss emerging stories in science and policy which elicit responses ranging from positive excitement to head-scratching concern.

Experience Nudge Learning! Interested in a new way of learning?